{"title": "Inherited mutation leads to overproduction of erythropoietin in blood", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Inherited mutation leads to overproduction of erythropoietin in blood"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/03/180308120612.htm"}], "link": "https://www.sciencedaily.com/releases/2018/03/180308120612.htm", "summary": "A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood. This mutation causes a messenger RNA (mRNA) that is not normally involved in the formation of proteins to be reprogrammed so that it produces EPO, thus abnormally increasing the number of red blood cells.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "A newly-discovered hereditary mutation is responsible for an increased production of erythropoietin (EPO) in the blood. This mutation causes a messenger RNA (mRNA) that is not normally involved in the formation of proteins to be reprogrammed so that it produces EPO, thus abnormally increasing the number of red blood cells."}, "published": "Thu, 08 Mar 2018 12:06:12 EST", "published_parsed": [2018, 3, 8, 17, 6, 12, 3, 67, 0], "id": "https://www.sciencedaily.com/releases/2018/03/180308120612.htm", "guidislink": false}